The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
about
Claims for the anabolic effects of growth hormone: a case of the emperor's new clothes?Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.In vitro and in vivo effects of IGF-I on adiposity in HIV-associated metabolic disease: a pilot studyPathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective.Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trialThe metabolic effects of lopinavir/ritonavir in HIV-negative menThe effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot studyNew and emerging agents in the management of lipodystrophy in HIV-infected patients.Growth hormone and tesamorelin in the management of HIV-associated lipodystrophyPharmacologic therapy for HIV-associated lipodystrophy.Update on HIV lipodystrophy.Current perspectives on HIV-associated lipodystrophy syndrome.Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management.HIV-associated lipodystrophy syndrome: A review of clinical aspects.Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men.Recombinant human growth hormone therapy in HIV-associated wasting and visceral adiposity.Growth hormone enhances thymic function in HIV-1-infected adultsToxic metabolic syndrome associated with HAART.Approach to the human immunodeficiency virus-infected patient with lipodystrophyLow-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trialStrategies in the treatment of HIV-1-associated adipose redistribution syndromes.The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.IGF-IR in neuroprotection and brain tumors.The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial.Growth and puberty in children with HIV infection.An update on the pharmacological strategies in the treatment of HIV-1-associated adipose redistribution syndromes.Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy.Low-dose growth hormone therapy reduces inflammation in HIV-infected patients: a randomized placebo-controlled study.Insulin-like growth factor-I-forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-α-mediated neuronal damage: implications for human immunodeficiency virus encephalitis.Benfluorex as a therapeutic option for insulin resistance in HIV lipodystrophy syndrome.Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone.Long-term effect on body composition and metabolic parameters after treatment with recombinant human growth hormone (r-hGH) in HIV-1 infected patients with lipodystrophy.Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update.
P2860
Q24672540-F2CF3ED3-1E91-4BD4-8367-C1E3783F172CQ34113192-B7A3A120-3542-44BA-B61A-8126E2381830Q34522890-9D3E5656-A9FC-4F90-B3D9-B448B6CB0049Q34650866-2EBBD874-F2FC-4BF0-98F2-014424926260Q34674697-94B7F1D3-6B1B-47B7-B74E-B3CA6DD6A364Q35194394-D43C2E4E-CD13-4FCF-82FA-097B6B91C344Q35206621-361EE996-A280-4E48-820F-19309F086AB2Q35557229-86B50939-5A44-43F6-8CD8-481632EEEED7Q35557342-7266573A-8B5B-47E1-9A81-C2B4C8BB97F8Q35644854-A777F0DA-59E5-4AA2-9C11-95E95D49FC39Q35833512-7B2526B8-5181-43D8-96E4-7C986351990EQ36132967-C838C9BF-8321-409E-857E-36BD20572FC9Q36158019-A251DAA3-7DAC-44BD-828E-21628A06D517Q36171069-FCB700E0-BE5F-45B9-A158-783084F7F379Q36206518-A65E086D-5DA7-4BAC-98BC-D64EEC914B2EQ36278045-0CCDC72E-4EAD-4DC8-96EE-6E6EF5A9ACEDQ36470468-93282989-D259-4193-8167-589E72EF8AECQ36544924-4D207C7A-A0C9-46F3-9A92-41F577E000E9Q36834945-962E7C42-ED8B-4851-BD98-BD245BA99408Q36868568-B5EACF16-C6C7-4E7C-8AE5-83E8304DBF61Q36909274-9AA1D8FE-C77E-41AE-B007-48B80A73EE23Q37193194-538128AC-0F30-4FEC-BD70-809B160653C3Q37409955-ABF3484E-C32B-474B-BE1E-D1638B080173Q37415273-4F567765-D0CA-431D-BBF3-C9DD6761C299Q37428510-302CB722-DFBF-469A-A4BC-8C9CD4FDC577Q38220651-DC56F378-4C66-4E01-8BF5-E376DD1538B1Q40500085-12617337-3CF4-4688-B6E0-2F50C6C1A12DQ40613036-4F7E6E1B-4E9B-4837-9A4C-5E4525EF132CQ41821482-4B433439-F480-4A82-AF34-23C31F0512FDQ44873296-8458AC93-743D-416C-A999-50FE7B7349D9Q46407316-D7B16CDB-2502-4169-8419-1A7D1F0B3E54Q51463523-C28A7F99-3BA9-4D26-8946-347CAF3468B9Q53691000-8F15C7EF-DC87-46D6-A8B0-064AE7EFC795
P2860
The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
The effects of recombinant hum ...... atients with fat accumulation.
@en
The effects of recombinant hum ...... atients with fat accumulation.
@nl
type
label
The effects of recombinant hum ...... atients with fat accumulation.
@en
The effects of recombinant hum ...... atients with fat accumulation.
@nl
prefLabel
The effects of recombinant hum ...... atients with fat accumulation.
@en
The effects of recombinant hum ...... atients with fat accumulation.
@nl
P2093
P356
P1476
The effects of recombinant hum ...... atients with fat accumulation.
@en
P2093
Grunfeld C
Halvorsen RA
Mulligan K
Schambelan M
Schwarz JM
P304
P356
10.1210/JCEM.86.8.7785
P407
P577
2001-08-01T00:00:00Z